Compound ID | 3313
Synonym(s): ABAC39877 | ABAC 39877
Class: Small molecule antibacterial agent
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against Acinetobacter baumannii; intended indication for hospital-acquired or ventilator-acquired bacterial pneumoniae |
| Institute where first reported: | ABAC Therapeutics |
| Year first mentioned: | 2018 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| External links: | |
| Citations: |
|